The independent source for health policy research, polling, and news.
30,001 - 30,020 of 112,494 Results
While the Virginia House shifted its stance on expanding the program after years of fighting it, the Senate hasn't budged. Media outlets report on Medicaid news out of Massachusetts, Ohio, Alabama and California, as well.
The 340B program requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income patients. Through Medicare, the federal government then reimburses the facilities for the drugs at a higher rate. A bill from Sen. Chuck Grassley (R-Iowa) would require hospitals to disclose how much they pay for drugs under the program.
Uber has announced it's launching a new branch called Uber Health, which will ferry patients to nonemergency medical appointments. It will be set up so that the medical provider would be billed for the service and not the patient.
Separately, the poll found that health care costs are the top health care issue that voters want to hear candidates talk about ahead of this year’s midterm elections. Meanwhile, Sen. Orrin Hatch (R-Utah) had some choice words for both the legislation and the "dumbass" people who support it.
President Donald Trump's latest nominee withdrew from consideration following allegations he exaggerated his work experience. Senators are calling on the administration to move quickly on a replacement.
The tone of tweets from both President Donald Trump and the lobbyist suggest that the president is walking back from the support he voiced the previous day for tighter gun restrictions. Meanwhile Democrats are calling for gun research funding at the same time a report finds that gun policy science is lacking overall.
The DEA annually sets the production and manufacturing quotas for Schedule I and II controlled substances. Between 1993 and 2015, the DEA approved a 39-fold increase of oxycodone, 12-fold increase of hydrocodone and a 25-fold increase of fentanyl.
At an opioid summit at the White House, President Donald Trump focused on criminal penalties, alarming advocates who want leaders to concentrate on treatment rather than punishment.
Today's early morning highlights from the major news organizations.
Opinion writers focus on these health issues and others.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from Florida, Minnesota, Illinois, Georgia, Massachusetts, Connecticut, Rhode Island, Missouri, Virginia, California, Ohio, Arizona, Wisconsin and Texas.
The restructuring of MassHealth is among the most significant health care initiatives to come from the administration of Gov. Charlie Baker, a Republican who has been focused on containing the costs of the massive program. In other Medicaid news: work requirements, premiums, and opioids.
Hospitals tend to be cornerstone institutions in rural communities, but many of them, under financial stress, are closing. Meanwhile, Community Health Systems' stock dropped amid reports of a $2 billion net loss in the fourth quarter.
Three-quarters of this year's pediatric flu deaths were in children who did not have a flu shot. In other public health news: eye health, c-sections, the "obesity paradox," diet soda, the cosmetics industry and hydration.
The number of people who were paying out of pocket for transgender surgeries plummeted to 39 percent between 2012 and 2014. Now, virtually every major medical association in the United States has described transition-related surgeries as “medically necessary.”
President Donald Trump plans to discuss the national epidemic with administration officials on Thursday, following this week's Capitol Hill hearings, about ways to curb the crisis. But advocates on the front lines are struggling with deep funding challenges.
Documents released by the ACLU show the decisions were made informally by email, memos and conversations rather than going through the normal legal process.
Doctors who get in trouble in one state can just move on to another, and often practice free and clear despite having been publicly disciplined, chastised or barred from practicing by state medical boards.
Newly installed Patent and Trademark Office Director Andrei Iancu holds substantial sway over an intellectual property system that, critics say, has allowed drug makers to extend their monopolies through legal but questionable tactics. In other pharmaceutical news: orphan drugs, FDA regulations, the "Pharma Bro" and more.
© 2026 KFF